Millennium Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-60,000
Closed -$3.19M 6145
2025
Q2
$3.19M Buy
60,000
+54,100
+917% +$2.75M ﹤0.01% 3442
2025
Q1
$255K Sell
5,900
-24,000
-80% -$1.22M ﹤0.01% 5179
2024
Q4
$1.68M Buy
29,900
+6,800
+29% +$423K ﹤0.01% 3781
2024
Q3
$1.57M Sell
23,100
-1,900
-8% -$107K ﹤0.01% 3919
2024
Q2
$1.06M Sell
25,000
-120,300
-83% -$6.62M ﹤0.01% 4077
2024
Q1
$10M Buy
145,300
+127,100
+698% +$8.04M ﹤0.01% 2190
2023
Q4
$1.35M Sell
18,200
-106,400
-85% -$6.97M ﹤0.01% 3929
2023
Q3
$8.5M Buy
124,600
+75,300
+153% +$6.39M ﹤0.01% 2200
2023
Q2
$4.63M Buy
+49,300
New +$3.85M ﹤0.01% 2749
2019
Q2
Sell
-30,000
Closed -$2.6M 4154
2019
Q1
$2.6M Buy
+30,000
New +$2.55M ﹤0.01% 2228

Other funds holding EXAS

Millennium Management's EXAS Position: Q1 2026 in Review

Millennium Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,441,516 shares — an estimated $350M sold.

Millennium Management first reported a position in EXAS in Q2 2013 and held it in 44 quarters. The position peaked at $350M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Millennium Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 3,441,516 Exact Sciences shares in Q1 2026, an estimated $350M.
  • Millennium Management first reported a position in Exact Sciences in Q2 2013 and held it in 44 quarters.
  • Millennium Management's Exact Sciences position peaked at $350M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.